Edgewise Therapeutics' Muscular Dystrophy Business acquired by Servier
Servier acquired Edgewise Therapeutics' Muscular Dystrophy Business, a therapeutics brand. Financial terms were not publicly disclosed. Public sources confirm the deal; valuation inputs may include estimates where transaction materials do not disclose the full economics.
Transaction summary
- Target
- Edgewise Therapeutics' Muscular Dystrophy Business
- Acquirer
- Servier
- Seller
- Edgewise Therapeutics
- Announced
- -
- Geography
- -
- Tags
- BiotechMuscular DystrophyPharmaTherapeutics
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-07-27
- Latest update
- 2026-08-03
Value and multiples
Price / value
Undisclosed
Transaction value
Basis: FundComb estimate
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Basis
- Financial terms were not disclosed in the public sources reviewed.
Source summary
Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business - PR Newswire
ConfirmedA PR Newswire release states that Servier completed its acquisition of Edgewise Therapeutics' muscular dystrophy business.
Open sourceServier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business - PR Newswire
ConfirmedA PR Newswire release states that Servier completed its acquisition of Edgewise Therapeutics' muscular dystrophy business.
Open source